The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT)

This study has been completed.
The EMMES Corporation
Information provided by (Responsible Party):
Joshua M Hare, University of Miami Identifier:
First received: October 3, 2008
Last updated: June 19, 2013
Last verified: June 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
No publications provided by University of Miami

Publications automatically indexed to this study by Identifier (NCT Number):